Skip to main content
. 2016 Oct 28;3(6):e297. doi: 10.1212/NXI.0000000000000297

Figure 1. Patient population included in the TYSEDMUS database.

Figure 1

Natalizumab (NZ) >3: strictly more than 3 NZ infusions; pregnancy (0): no pregnancy during the year after NZ stop; Expanded Disability Status Scale (EDSS) M0 and M12: EDSS score available the month of the last NZ infusion and at 12 months after NZ discontinuation.